Actively Recruiting
Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study
Led by Medstar Health Research Institute · Updated on 2025-12-24
25
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
Sponsors
M
Medstar Health Research Institute
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients living with cancer commonly have chronic pain due to the disease or to cancer treatments. Virtual reality, a new technology that immerses the user in pleasant, diverting, and exciting virtual environments, may lower chronic cancer pain to improve quality of life and complement need for pain medications like opioids. The investigators aim to learn from patients about the experience of cancer pain, develop a virtual reality prototype specific to cancer pain management, and test the feasibility and acceptability of this technology to improve the cancer pain experience.
CONDITIONS
Official Title
Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Living with an active cancer diagnosis of any solid tumor type
- Experiencing chronic cancer pain for 3 months or longer with a baseline pain score of 4 or higher on a 0 to 10 scale
- Currently prescribed chronic opioid therapies, including long-acting, short-acting formulations, or both
You will not qualify if you...
- History of severe nausea, vomiting, motion sickness, seizures, epilepsy, or cranial abnormalities preventing use of a virtual reality headset
- Moderate to severe pain that is not caused by cancer (e.g., chronic lower back pain)
- Currently enrolled in another pain-related clinical study
- Unable to complete surveys in English or Spanish
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
Research Team
H
Hunter Groninger, MD
CONTACT
E
Eloisa Leiva
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here